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Glucosinolates are naturally occurring amino acid-derived S-glu-
cosides of thiohydroximate-O-sulfonates. They co-occur with endog-
enous thioglucosidases called myrosinases that upon tissue damage 
hydrolyze glucosinolates into a wide range of degradation products 
such as e.g. isothiocyanates, nitriles, and thiocyanates. Glucosino-
lates (or rather their degradation products) are involved in plant de-
fense and constitute characteristic fl avor compounds and cancer-pre-
ventive agents in Brassica vegetables. 
The biosynthetic pathway from precursor amino acid to the core 
glucosinolate structure has been well studied, and many of the inter-
mediates are known, including oximes, thiohydroximic acids, and 
desulfoglucosinolates (1, 2). Recently, it has been shown that cyto-
chromes P450 belonging to the CYP79 family catalyze the conver-
sion of amino acids to oximes (3–7). Little is known about the forma-
tion of thiohydroximic acids from oximes. The remaining part of the 
pathway for the core structure involves a UDP-glucose:thiohydrox-
imic acid glucosyltransferase and a sulfotransferase (for review, see 
Ref. 2). 
It has been proposed that aci-nitro compounds are intermediates 
in the conversion of oximes to thiohydroximic acids (8). This was 
supported by isolation of 1-nitro-2-phenylethane from Tropaeolum 
majus shoots and by in vivo conversion of phenylacetaldoxime into 
1-nitro-2-phenylethane and of 1-nitro-2-[1,2-14C]phenylethane into 
benzylglucosinolate (9). The aci-nitro is proposed to be conjugated 
with a sulfur donor to produce an S-alkyl thiohydroximate, possibly 
by a glutathione S-transferase (2). Biochemical studies indicate that 
the S-alkyl thiohydroximate is subsequently hydrolyzed to the thio-
hydroximic acid by a C-S lyase (10). 
Glucosinolates are related to cyanogenic glucosides because both 
groups of natural plant products are derived from amino acids and 
have oximes as intermediates. This suggests that the oxime-metab-
olizing enzyme is the branching point between the cyanogenic glu-
coside and the glucosinolate pathway. In the biosynthetic pathway 
of the tyrosine-derived cyanogenic glucoside dhurrin from Sorghum 
bicolor, the oxime-metabolizing enzyme (designated P450ox or 
CYP71E1) catalyzes the conversion of oxime to α-hydroxynitrile by 
dehydrating the oxime to a nitrile, which is then C-hydroxylated to 
form the β-hydroxynitrile (11, 12). 
We have previously used Sinapis alba as a model plant for bio-
synthetic studies of the glucosinolate pathway (13). The tyrosine-
derived p-hydroxybenzylglucosinolate is the major glucosinolate in 
S. alba. In the present study, we characterize biochemically the ox-
ime-metabolizing enzyme in microsomes from S. alba and show that 
the enzyme is dependent on a cytochrome P450 monooxygenase. In 
addition, we show that CYP83B1 is the oxime-metabolizing enzyme 
in glucosinolate biosynthesis in Arabidopsis thaliana as evidenced 
by biochemical characterization of the recombinant protein. The data 
substantiate the results recently obtained with the rnt1-1 CYP83B1 
knock-out mutant (29). 
EXPERIMENTAL PROCEDURES
Chemical Synthesis 
S-(Benzohydroximoyl)-L-cysteine—N-Chlorosuccinimide (280 g, 21 mmol) 
and HCl gas (40 ml) were added to benzaldoxime (2.42 g, 20.0 mmol) in dimeth-
ylformamide (40 ml) and stirred at room temperature for 4 h. Water (150 ml) was 
added, and the reaction mixture was extracted with diethyl ether (3 × 50 ml). 
The combined ether phases were washed with water (2 × 50 ml), dried, and con-
centrated in vacuo. The residue oil containing the benzohydroximic acid chlo-
ride was dissolved in ethanol (50 ml) and added to a solution of ice-cold L-cys-
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teine (3.15 g, 20.0 mmol) in ethanol (100 ml). The mixture was treated with 
sodium methoxide (sodium 0.74 g, 32.2 mmol; methanol 50 ml) and left stirring 
for 3 h. The white precipitate was fi ltered, and the fi ltrate was concentrated in 
vacuo, washed in water, and dried (3.42 g, 71%). NMR in D2O/NaOD: 
1H δ 7.4-
7.5 (5H, m, Ph), 3.28 (1H, dd, J 8.3, 3.9 Hz, CH), 2.85 (1H, dd, J 13.2, 8.3 Hz, 
CH2), 3.13 (1H, dd, J = 13.2, 3.9 Hz,
 CH2); 
13C: δ 168.4 (COOH), 150.9 (S-
C=N), 133.7, 128.4, 128.4, 129.1 (Ph), 53.3 (CH), 52.7 (CH2). MS
1: [M + Na]+ 
at m/z 263, [M + H]+ at m/z 241, fragment ions at m/z 224, m/z 195, m/z 154, and 
m/z 120. After a few hours in methanol, the product underwent cyclization with 
concomitant release of hydroxylamine to produce (R)-2-phenyl-thiazoline-4-car-
boxylic acid. NMR (Me2SO-d6): 
1H δ 7.4-7.8 (5H, m, Ph), 5.17 (1H, t, J 9 Hz, 
CH), 3.62 (2H, d, J 9 Hz, CH2); 
13C: δ 172.6 (S-C=N), 167.7 (COOH), 133.0 
131.7 128.3 128.9 (Ph), 80.2 (CH), 35.7 (CH2). MS: [M + H]
+ at m/z 208, frag-
ment ion at m/z 162. 
S-(Benzohydroximoyl)-N-acetyl-L-cysteine—Benzohydroximic acid chlo-
ride (1.55 g, 10 mmol) diluted with tetrahydrofuran was added dropwise to 
ice-cold N-acetyl-L-cysteine (1.63 g, 10 mmol) in tetrahydrofuran (30 ml) with 
triethylamine (4.04 g, 0.04 mmol). After stirring for an additional 30 min, di-
lute sulfuric acid (5% v/v, 100 ml) was added, the tetrahydrofuran was re-
moved in vacuo, and the aqueous layer was left at room temperature for 48 h. 
The white precipitate was fi ltered, and the fi ltrate was washed in diethyl ether 
and dried (2.06 g, 73%). NMR (D2O,
 NaOD): 1H: d 1.95 (3H, s, CH3CO), 
2.98 (1H, dd, J 5.0, 14.0, CHaHbCH), 3.00 (1H, dd,
 J 5.0, 14.0, CHaHbCH), 
4.17 (1H, t, J 5.0, CHaHbCH) 7.40-7.49
 (5H, m, 5× ArH), 13C: d 24.8 (COCH3), 
35.1 (CH2), 57.6 (CH), 131.4 (2× CH), 131.5
 (CH), 131.6 (2× CH), 137.0 (Cq), 
155.3 (C=NOH), 175.8 (CO), 179.2 (CO). MS: [M + Na]+ at m/z 305, [M + H]+ 
at m/z 283, fragment ions at m/z 208, m/z 162, and m/z 130. 
Preparation of Microsomal Enzyme System from S. alba 
Seeds of S. alba were germinated in darkness and jasmonate-treated as 
previously described (13). The preparation of microsomes was done as previ-
ously described (13) except that the isolation buffer was modifi ed to consist of 
250 mM Tricine, 100 mM ascorbic acid, 2 mM EDTA, and 2 mM dithiothreitol, 
pH 8.2. The same procedure was used to prepare microsomes from seedlings of 
T. majus, S. bicolor, and Zea mays. 
Measurements of Oxime-metabolizing Enzyme Activities in 
Microsomes from S. alba 
[U-14C]p-Hydroxyphenylacetaldoxime was produced enzymatically by 
CYP79A1 as previously described (14). In a typical enzyme assay, 1 mg of mi-
crosomal protein was incubated in buffer containing 30 mM KPi, pH 7.9, 3 mM 
NADPH, 38 nCi (66 pmol) of [U-14C]p-hydroxyphenylacetaldoxime, and 6 mM 
cysteine or N-acetylcysteine in a total volume of 200 μl. After incubation at 
29 °C for 1 h, the reaction mixtures were extracted twice with 400 μl of ethyl ac-
etate. If N-acetylcysteine was used as a sulfur donor, the remaining water phases 
were acidifi ed by addition of 200 μl of 1% formic acid and extracted three times 
with 800 μl of ethyl acetate. The ethyl acetate phases were combined and dried 
in vacuo. The extracts were redissolved in 30 μl of 50% ethanol and analyzed by 
TLC. If cysteine was used as a sulfur donor 400 μl of 96% ethanol were added 
to the remaining water phases, and the solution was clarifi ed by centrifugation 
for 15 min at 20,000 × g. The supernatants were concentrated in vacuo, redis-
solved in 30 μl of 50% ethanol, and analyzed by TLC. Boiled microsomes were 
used in control assays. For analysis of the effect of treatment with cytochrome 
P450 inhibitor, standard microsomal reaction mixtures were incubated in the 
presence of 0.1 mM tetcyclasis. The TLC was performed on Silica Gel 60 F254 
sheets (Merck) using 2-propanol:ethyl acetate:water (7:1:2, v/v) as eluent. The 
TLC plates were eluted twice to improve separation. Radiolabeled bands were 
visualized and quantifi ed on a STORM 840 PhosphorImager (Molecular Dy-
namics, Sunnyvale, CA). For LC-MS analysis, 5 × 200 μl of reaction mixtures 
were made as described above except that [U-14C]p-hydroxyphenylacetaldox-
ime was exchanged for 3 mM unlabeled oxime. The compounds were extracted 
from the reaction mixtures as described above. 
LC-MS Analysis 
Electrospray ionization LC-MS analysis was done on a HP1100 LC coupled 
to a Bruker Esquire-LC ion trap mass spectrometer. The reversed-phase LC con-
ditions were as follows: column: XTerra MS C18 3.5 μm, 2.1 × 100 mm (Waters 
Corp.); mobile phases A: 0.03% HCOOH, B: 80% MeCN, 0.1% HCOOH. The 
fl ow rate was 0.2 ml/min, and the gradient program was 0-2 min isocratic 5% B,
2-30 min linear gradient 5-100% B, and 30-35 min isocratic 100% B. The mass 
spectrometer was run in positive ion mode using a low sampling cone voltage 
to minimize fragmentation. Authentic standards of S-(benzohydroximoyl)-L-cys-
teine and S-(benzohydroximoyl)-N-acetyl-L-cysteine were synthesized and used 
to develop conditions for the recording of mass spectra of analogue compounds 
(see above). 
Phylogenetic Trees 
The protein sequences of all the members of the CYP71 family were cor-
rected for prediction errors, and the full-length sequences were aligned including 
one member of each of the families CYP76, CYP98, and CYP84 using ClustalW 
(15). Phylogenetic analysis was performed with the Protdist and Fitch (Fitch-
Margoliash and least squares method) programs of the Phylip package (16). 
Generation of the Constructs for Escherichia coli Expression 
The ESTs 226P8T7, 5G6, and 148G2T7 (Arabidopsis Biological Resource 
Center, Columbus, OH), which encode the full-length sequences of CYP71B6, 
CYP71B7, and CYP83B1, respectively, were expressed heterologously in E. coli 
using the pSP19 g10L expression vector (17). Silent mutations were introduced 
to enrich for A and T in the fi rst 11 codons (17). The coding region of CYP71B6 
was amplifi ed from the EST 226P8T7 by PCR with primer 1 (sense direction; 
5’-GGAATTCCATATGTCACTTTTATCTTTCCCCATT-3’) and primer 2 (an-
tisense direction; 5’-GGCTGCAGGCATGCTTAAAGCTTGCGGTTGATGA-
3’). The PCR was set up in a total volume of 100 μl in Pwo polymerase PCR 
buffer with 2 mM MgSO4 using 4 units of Pwo polymerase (Roche Molecu-
lar Biochemicals), 1.3 μg of template DNA, 200 μM dNTPs, and 100 pmol of 
each primer. The PCR was incubated for 2 min at 94 °C, 21 cycles of 15 s at 
94 °C, 20 s at 56 °C, and 70 s at 72 °C. The PCR fragment was digested with 
EcoRI and PstI, ligated into pBluescript II SK (Stratagene), and transferred from 
pBluescript II SK to an NdeI/SphI-digested pSP19 g10L vector. The CYP71B7 
gene was PCR-amplifi ed from EST 5G6 using primer 3 (sense direction; 5’-
GGAATTCATATGGCTATCTTGCTCTGTTTC-3’) and primer 4 (antisense di-
rection; 5’-CGGGATCCCATGATCGTCATCTTAATGATG-3’). The PCR was 
set up as described above. The PCR was incubated for 2 min at 94 °C, 23 cy-
cles of 15 s at 94 °C, 45 s at 55 °C, and 2 min at 72 °C. The PCR product was 
digested with EcoRI and BamHI, ligated into pBluescript II SK, and trans-
ferred from pBluescript II SK into an NdeI/BamHI-digested pSP19 g10L. The 
CYP83B1 coding region was amplifi ed from the EST 148G2T7 by PCR with 
primer 5 (sense direction; 5’-GGAATTCCATATGAAACTCTTATTGAT-
TATAGCTGGTTTAGTTGCGGCTGCAG-3’) and primer 6 (antisense direc-
tion; 5’-CGGGATCCATTAGATGTGTTTCGTTGGTGC-3’). The PCR was set 
up as described above. The PCR was incubated for 2 min at 94 °C, 22 cycles 
of 15 s at 94 °C, 20 s at 57 °C, and 70 s at 72 °C. The PCR fragment was di-
gested with EcoRI and BamHI, ligated into pBluescript II SK, and transferred 
from pBluescript II SK to a NdeI/BamHI-digested pSP19 g10L vector. All con-
structs were sequenced to exclude PCR errors. 
Expression in E. coli 
E. coli cells of strain C43(DE3) (18) were transformed with the expression 
constructs and grown overnight in LB medium supplemented with 100 μg ml–
1 ampicillin. 2 ml of culture was used to inoculate 200 ml of modifi ed TB me-
dium containing 50 μg ml–1 ampicillin (14). The cultures were grown at 37 °C at 
250 rpm until A600 = 0.5-0.7. Then 1 mM thiamine and 75 μg ml
–1 δ-aminolev-
ulinic acid were added, and after an additional 1 h of growth, the cultures were 
induced with 1 mM isopropyl-β-D-thiogalactoside and subsequently grown at 
28 °C for 40 h at 125 rpm. Spheroplasts were prepared as previously described 
(14) except that glycerol was omitted in the fi nal buffer. The amount of ex-
pressed functional cytochrome P450 was monitored by Fe2+·CO versus Fe2+ dif-
ference spectroscopy and quantifi ed using an extinction coeffi cient of 91 mM–
1 cm–1. 
Characterization of Enzyme Activity of Recombinant CYP71B6, CYP71B7, and 
CYP83B1 
The enzyme activity of CYP71B6, CYP71B7, and CYP83B1 was mea-
sured in reaction mixtures in which spheroplasts of E. coli transformed with the 
respective expressing construct were reconstituted with recombinant NADPH:
cytochrome P450 reductase (ATR1) from A. thaliana. In a typical enzyme as-
say, 25 μl of spheroplasts and 0.06 units of NADPH:cytochrome P450 reductase 
were incubated in buffer containing 50 mM Tricine, pH 8.1, 3 mM NADPH, 
38 nCi (66 pmol) of [U-14C]p-hydroxyphenylacetaldoxime, and 6 mM cys-
teine or N-acetylcysteine in a total volume of 100 μl. Spheroplasts of E. coli 
1 Abbreviations: MS, mass spectrometry; LC, liquid chromatography; EST, ex-
pressed sequence tag; PCR, polymerase chain reaction.
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C43(DE3) transformed with empty vector were used as controls. After incuba-
tion at 29 °C for 1 h, the reaction mixtures were extracted and analyzed as de-
scribed for the microsomal assays. Product formation from the oxime was linear 
with time within the fi rst 10 min of incubation. For kinetic analysis, 5-50 μM p-
hydroxyphenylacetaldoxime was added to the standard reaction mixture, which 
was incubated for 5 min and analyzed by TLC as described above. Radiolabeled 
bands were visualized and quantifi ed on a STORM 840 PhosphorImager. For 
LC-MS analysis, 10 reactions of 100 μl were done as described above except 
that radiolabeled p-hydroxyphenylacetaldoxime was exchanged with 3 mM un-
labeled oxime. 
Substrate Binding Spectra 
Substrate binding spectra were measured for recombinant CYP83B1 us-
ing partially purifi ed enzyme. Purifi cation was obtained by temperature-in-
duced Triton X-114 phase partitioning of E. coli spheroplasts as previously de-
scribed (14). The substrate binding spectra were performed on an SLM Aminco 
DW-2000 TM spectrophotometer (SLM Instruments, Urbana, IL) at 12 °C us-
ing 10 μl of the Triton X-114-rich phase in 990 μl of 50 mM KPi, pH 7.5, and 
0.2 mM of either p-hydroxyphenylacetaldoxime, p-hydroxyphenylacetonitrile, 
1-nitro-2-(p-hydroxyphenyl)ethane, or p-hydroxyphenylacetamide. 
RESULTS
Characterization of the Oxime-metabolizing Enzyme in Micro-
somes from S. alba—Biosynthetically active microsomes from S. alba 
seedlings were isolated under conditions where myrosinase was in-
hibited to prevent formation of inhibitory breakdown products from 
the glucosinolates in the tissue (13). When [U-14C]p-hydroxyphen-
ylacetaldoxime and cysteine were added to microsomes from S. alba 
in the presence of NADPH, a cysteine-dependent radiolabeled com-
pound accumulated in the reaction mixtures as evidenced by TLC 
analysis (Figure 1, column 2). The compound was not detectable 
when boiled microsomes were used (Figure 1, column 4), indicating 
that the reaction required the presence of an active enzyme. The prod-
uct formation was signifi cantly reduced when NADPH was not added 
to the reaction mixture, further emphasizing that the reaction was en-
zyme-dependent and the electron source was NADPH (Figure 1, col-
umn 3). When the reaction mixtures were extracted with ethyl ace-
tate, the cysteine-dependent compound remained in the water phase, 
whereas the oxime accumulated in the ethyl acetate phase. The water 
solubility indicated that the cysteine-dependent compound contained 
the polar groups of cysteine. The characteristics were consistent with 
the compound being the proposed intermediate S-(p-hydroxyphenyl-
acetohydroximoyl)-L-cysteine, also referred to as cysteine conjugate. 
Such cysteine conjugates undergo cyclization with concomitant re-
lease of hydroxylamine to produce the corresponding 2-substituted 
thiazoline-4-carboxylic acids as evidenced by the chemically synthe-
sized authentic standard S-(benzohydroximoyl)-L-cysteine (Figure 2). 
The cyclization product (R)-2-(p-hydroxybenzyl)-thiazoline-4-car-
boxylic acid formed from S-(p-hydroxyphenylacetohydroximoyl)-L-
cysteine with [M + H]+ at m/z 238 was identifi ed by LC-MS (Figure 
3, A and B). In the presence of tetcyclasis, an inhibitor of cytochrome 
P450, the production of cysteine conjugate was signifi cantly reduced 
(Figure 1, column 5). This indicated that the oxime-metabolizing en-
zyme in the glucosinolate pathway is a cytochrome P450-dependent 
monooxygenase. 
When N-acetylcysteine was used as a sulfur donor in the micro-
somal reaction mixtures containing [U-14C]p-hydroxyphenylacetal-
doxime and NADPH, an N-acetylcysteine-dependent compound was 
produced as evidenced on TLC (Figure 1, column 7). The N-acetyl-
cysteine-dependent compound was not present when boiled micro-
somes were used (Figure 1, column 9), and the product formation 
was signifi cantly reduced when NADPH was not added to the re-
action mixture (Figure 1, column 8), showing that the reaction was 
enzyme-dependent and the electron source was NADPH. The pro-
duction was inhibited by tetcyclasis as was seen for the cysteine 
conjugate compound (Figure 1, column 10). The N-acetylcysteine-
dependent compound was identifi ed by LC-MS analysis as S-(p-hy-
droxyphenylacetohydroximoyl)-N-acetyl-L-cysteine, also referred 
to as N-acetylcysteine conjugate (Figure 3, C and D). In contrast to 
the cysteine conjugate, no cyclization of the N-acetylcysteine conju-
gate took place, refl ecting that the nucleophilic property of the amine 
(cysteine) is considerably greater than that of the amide (N-acetylcys-
teine). Rearrangement, as shown in Figure 2D, can only take place if
Figure 1.   Production of the cysteine conjugate (cys.cj.), the N-acetylcysteine 
conjugate (N-Ac-cys.cj.), and an unidentifi ed compound (X) by S. alba micro-
somes. [U-14C]p-Hydroxyphenylacetaldoxime was incubated with microsomes 
from S. alba in the presence of cysteine (columns 1-5) or N-acetylcysteine (col-
umns 6-10) as a sulfur donor. The reaction mixtures were extracted with ethyl ace-
tate, and the water phases were analyzed by TLC. As a control boiled microsomes 
were used (columns 4 and 9). In the absence of a sulfur donor a compound (X) ac-
cumulated (columns 1 and 6). The production of the conjugates was inhibited by 
the cytochrome P450 inhibitor tetcyclasis (columns 5 and 10).
Figure 2.   LC-MS analysis of S-(benzohydroximoyl)-L-cysteine. A, LC-MS 
analysis of S-(benzohydroximoyl)-L-cysteine (I) dissolved in methanol. The total 
ion chromatogram shows the starting material as Peak a and the pre-injection cy-
clized product, (R)-2-phenyl-thiazoline-4-carboxylic acid (II) as Peak b. The rising 
baseline between the two peaks stems from on-column cyclization. B, mass spec-
trum of Peak a: I gives rise to the ions [M + Na]+ at m/z 263 and [M + H]+ at m/
z 241. C, mass spectrum of Peak b: II gives rise to the ion [M + H]+ at m/z 208. D, 
scheme illustrating the cyclization process of S-(benzohydroximoyl)-L-cysteine to 
(R)-2-phenyl-thiazoline-4-carboxylic acid.
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the N-acetyl group is eliminated; this was not seen over the time 
course of the reaction. It may take place, however, if the reaction 
is allowed to proceed for a longer period of time during which hy-
drolysis occurs. By the LC-MS analysis of the N-acetylcyste-
ine conjugate two peaks were seen at retention times of 12.9 and 
14.6 min corresponding to the E- and Z-isomers of the hydroximino 
group of the molecule, respectively. The two isomers had identical 
mass spectra with [M + Na]+ at m/z 335, [M + H]+ at m/z 313, and 
fragments at m/z 162, 130, and 107 (Figure 3D). Very low sam-
pling cone voltage was required for detection of the molecular ion. 
The conditions for detecting the molecular ion were developed us-
ing the authentic standards S-(benzohydroximoyl)-L-cysteine and 
S-(benzohydroximoyl)-N-acetyl-L-cysteine. 
When [U-14C]p-hydroxyphenylacetaldoxime and NADPH 
were added to microsomes from S. alba in the absence of a sulfur 
donor, a radiolabeled compound (X) accumulated in the reaction 
mixtures as evidenced by TLC (Figure 1, columns 1 and 6). The ac-
cumulation of this product (X) was reduced when a sulfur donor was 
added (Figure 1, columns 2 and 7). Another compound accumulated 
in low amounts in ethyl acetate extracts of the reaction mixtures (data 
not shown). The compound co-migrated with authentic 1-nitro-2-(p-
hydroxyphenyl)ethane. The identity of the compound was confi rmed 
by gas chromatography-MS (data not shown). The specifi city of the 
oxidation of oxime to nitro for the glucosinolate biosynthetic path-
way was investigated by testing the ability of microsomes isolated 
from another glucosinolate-producing plant (T. majus) and a non-glu-
cosinolate-producing plant (Z. mays) to produce the nitro compound. 
Both T. majus and maize were able to convert the p-hydroxyphenyl-
acetaldoxime into 1-nitro-2-(p-hydroxyphenyl)ethane, showing that 
the reaction is not specifi c for glucosinolate-producing plants. 
Phylogenetic Analysis— The activity of the oxime-metabolizing 
enzyme in microsomes in S. alba was too low to pursue a biochemi-
cal approach to identify the cytochrome P450 involved, which we for 
evolutionary reasons expected to be related to the oxime-metabolizing 
enzyme in the cyanogenic pathway. Considering the rapid advance 
of the genome-sequencing project of A. thaliana, we took a bioinfor-
matics approach to search for homologues of CYP71E1 (P450ox), 
which presently is the only oxime-metabolizing enzyme identifi ed in 
the biosynthetic pathway of cyanogenic glucosides (12). In addition 
to the cytochromes designated CYP71s, members of the CYP83 fam-
ily belong correctly to the CYP71 family based on sequence similar-
ity.2 With the sequences available at the given time (summer/autumn 
1999), we combined BLAST searches and sequence alignments, ex-
pression data (19), and mutant phenotypes (20)3 to identify candi-
dates for the oxime-metabolizing enzyme in A. thaliana. Among the 
candidate genes found in the closest related subfamilies, CYP71B7, 
2 S. Paquette and S. Bak, personal communication. 
3 S. Bak, personal communication.
Figure 3.   Identifi cation by LC-MS of (R)-2-(p-hydroxybenzyl)-thiazoline-4-
carboxylic acid and of S-(p-hydroxyphenylacetohydroximoyl)-N-acetyl-L-cys-
teine produced by S. alba microsomes. A, reconstructed ion chromatogram of 
m/z 238. B, mass spectrum of the cyclization product (R)-2-(p-hydroxybenzyl)-
thiazoline-4-carboxylic acid of S-(p-hydroxyphenylacetohydroximoyl)-L-cyste-
ine showing [M + H]+ at m/z 238 and fragment ion at m/z 107. C, reconstructed 
ion chromatogram (m/z 313) showing the E- and Z-isomers of the product S-(p-
hydroxyphenylacetohydroximoyl)-N-acetyl-L-cysteine (I) and reconstructed ion 
chromatogram (m/z 152) showing E- and Z-isomers of the substrate p-hydroxy-
phenylacetaldoxime (II). D, mass spectrum of S-(p-hydroxyphenylacetohydroxi-
moyl)-N-acetyl-L-cysteine showing [M + Na]+ at m/z 335, [M + H]+ at m/z 313, and 
fragment ions at m/z 162, 130, and 107.
Figure 4.   A phylogenetic tree of the CYP71 family in A. thaliana and 
CYP71E1 (P450ox) from S. bicolor. The tree was constructed by alignment of the 
amino acid sequences using ClustalW. Phylogenetic analysis was performed with 
the Protdist and Fitch (Fitch-Margoliash and least squares method) programs of the 
Phylip package. Despite their original name, the CYP83s belong correctly to the 
CYP71 family. CYP76C4, CYP98A3, and CYP84A1 are included as outgroups. 
CYP71B7, CYP71B6, and CYP83B1 were tested earlier as candidates for the ox-
ime-metabolizing enzyme in the glucosinolate pathway.
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CYP71B6, and CYP83B1 existed as full-length ESTs and were ex-
pressed in E. coli. After completion of the genome-sequencing proj-
ect of A. thaliana, a phylogenetic tree of the CYP71 family was made 
(Figure 4). 
Heterologous Expression of CYP71B6, CYP71B7, and CYP83B1 
in E. coli— CYP71B6, CYP71B7, and CYP83B1 were expressed in 
E. coli strain C43(DE3) by use of the expression vector pSP19 g10L. 
CO difference spectrum with the characteristic peak at 450 nm was 
obtained for CYP71B7 and CYP83B1 indicating the presence of 
functional cytochrome P450 (Figure 5). Based on the peak at 450 nm, 
the expression levels of CYP71B7 and CYP83B1 were estimated to 
be 50 and 430 nmol of cytochrome P450 (liter of culture) 1, respec-
tively. The expression of CYP71B6 in E. coli did not result in pro-
duction of a protein giving a peak at 450 nm in a CO difference spec-
trum; this, however, does not exclude the presence of a functional 
protein (4). When [U-14C]p-hydroxyphenylacetaldoxime and cys-
teine or N-acetylcysteine were added to spheroplasts of E. coli ex-
pressing CYP83B1 reconstituted with NADPH:cytochrome P450 re-
ductase in the presence of NADPH, a compound accumulated in the 
reaction mixtures that co-migrated with the cysteine conjugate (Fig-
ure 6, column 4) and the N-acetylcysteine conjugate (Figure 6, col-
umn 9) produced by the S. alba microsomes as evidenced by TLC. 
Formation of these products was furthermore shown to be depen-
dent on NADPH as the electron source (Figure 6, columns 5 and 
10). The products were not detected in reaction mixtures contain-
ing E. coli spheroplasts harboring either the CYP71B6 or CYP71B7 
(data not shown) or empty vector (Figure 6, columns 1 and 6). The 
compounds produced from p-hydroxyphenylacetaldoxime by recom-
binant CYP83B1 using cysteine or N-acetylcysteine as a sulfur do-
nor were identifi ed by LC-MS analysis as the cyclization product of 
S-(p-hydroxyphenylacetohydroximoyl)-L-cysteine or the (uncycliz-
ing) S-(p-hydroxyphenylacetohydroximoyl)-N-acetylcysteine (data 
not shown), respectively. Recombinant CYP83B1 has a pH optimum 
of 8.1, and kinetic studies showed that it has a turnover number of 
16 min–1 and a Km of 68 μM for p-hydroxyphenylacetaldoxime. 
When radiolabeled oxime and NADPH were incubated with 
recombinant CYP83B1 in the absence of a sulfur donor, a radio-
labeled compound accumulated in the reaction mixture that co-
migrated with the unidentifi ed compound that accumulated in 
the S. alba microsomal reaction mixtures under the same condi-
tions as evidenced by TLC (Figure 6, columns 3 and 8). Several at-
tempts to identify the compound (X) were unsuccessful. Accumu-
lation of the unidentifi ed product (X) and of radiolabeling retained 
at the application site was greatly reduced when a sulfur donor was 
added (Figure 6, columns 4 and 9). No detectable amounts of 1-ni-
tro-2-(p-hydroxyphenyl)ethane accumulated in the reaction mixtures 
containing recombinant CYP83B1. Furthermore, neither 1-nitro-2-
(p-hydroxyphenyl)ethane nor p-hydroxyphenylacetonitrile was me-
tabolized by CYP83B1 (data not shown). This indicates that neither 
the nitro compound nor nitrile is involved in the reaction catalyzed 
by CYP83B1. 
Substrate Binding to CYP83B1— We analyzed spectrally the 
binding of substrate and potential intermediates to CYP83B1. Re-
combinant CYP83B1 was partially purifi ed from E. coli sphero-
plasts by temperature-induced phase partitioning, which produced 
a detergent rich-phase containing the majority of the cytochrome 
P450. Recombinant CYP83B1 produced a type I spectrum with p-hy-
droxyphenylacetaldoxime (λmax 390 nm
 and λmin 427 nm), p-hydroxy-
phenylacetonitrile (λmax 391 nm and
 λmin 427 nm), and 1-nitro-2-(p-
hydroxyphenyl)ethane (λmax 391
 nm and λmin 427 nm) indicating a 
shift from a low to a high spin state upon substrate binding (21) (Fig-
ure 7, a, b, and c). The amplitude increased in size upon incubation 
and reached a stable maximum after ~30 min. No substrate binding 
spectrum was obtained upon the addition of p-hydroxyphenylacet-
amide (data not shown). Although neither the nitrile nor nitro com-
pound was metabolized by CYP83B1, the formation of type I binding 
spectra demonstrated that CYP83B1 was able to bind these analogues. 
DISCUSSION
In the present study, we have characterized biochemically the 
conversion of p-hydroxyphenylacetaldoxime to S-(p-hydroxyphenyl-
acetohydroximoyl)-L-cysteine in microsomes from S. alba and shown 
that the enzyme activity was dependent on a cytochrome P450 mo-
nooxygenase. By combined use of bioinformatics, published expres-
sion data, and knock-out phenotypes, we identifi ed CYP83B1 as the 
oxime-metabolizing enzyme in the glucosinolate pathway. We have 
used the tyrosine-derived oxime as substrate, although A. thaliana 
does not produce the tyrosine-derived p-hydroxybenzylglucosinolate. 
We have, however, previously shown that A. thaliana is capable of 
converting p-hydroxyphenylacetaldoxime into p-hydroxybenzylglu-
cosinolate (22). 
Figure 5.   Carbon monoxide difference spectra of CYP71B7 and CYP83B1. 
The Fe2+·CO versus Fe2+ difference spectra were measured on spheroplasts of 
E. coli expressing CYP71B7, CYP83B1, or empty vector. The spectra were re-
corded at 12 °C.
Figure 6.   Production of the cysteine conjugate (cys.cj.), the N-acetylcyste-
ine conjugate (N-Ac-cys.cj.), and an unidentifi ed compound (X) by CYP83B1 
(83B1). [U-14C]p-Hydroxyphenylacetaldoxime was incubated with recombinant 
CYP83B1 reconstituted with NADPH:cytochrome P450 reductase in the presence 
of cysteine (columns 2-5) or N-acetylcysteine (columns 7-10) as a sulfur donor. 
The reaction mixtures were extracted with ethyl acetate, and the water phases were 
analyzed by TLC. In the absence of a sulfur donor a compound (X) accumulated 
(columns 3 and 8). Empty vector was used as a control (c) (columns 1 and 6).
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S-(Hydroximoyl)-L-cysteine is the most likely S-alkyl thiohy-
droximate in the glucosinolate pathway for several reasons. First, in 
vivo feeding studies have shown that among other sulfur donors, cys-
teine is most effi ciently incorporated into glucosinolates (23). Sec-
ond, the enzyme that converts S-alkyl thiohydroximate to thiohydrox-
imate is likely to be a C-S lyase, and the characterized C-S lyases 
from plants hydrolyze S-substituted cysteine derivatives and have an 
absolute requirement for the presence of the α-hydrogen atom and an 
unsubstituted amino group in the cysteine moiety (10, 24). We have 
succeeded for the fi rst time in obtaining a mass spectrum providing 
evidence for enzymatic synthesis of the proposed intermediate S-(p-
hydroxyphenylacetohydroximoyl)-L-cysteine. In vitro S-(p-hydroxy-
phenylacetohydroximoyl)-L-cysteine undergoes cyclization, which 
indicates that the proposed C-S lyase is tightly coupled to the sulfur-
conjugating enzyme in vivo. 
For the oxime to be converted into the S-alkyl thiohydroximate, 
it needs to be oxidized prior to conjugation with the sulfur donor. We 
have shown the production of 1-nitro-2-(p-hydroxyphenyl)ethane 
from p-hydroxyphenylacetaldoxime in microsomes from S. alba, 
T. majus, and Z. mays. Although recombinant CYP83B1 is able to 
bind the nitro to the active site, no nitro production or metabolism by 
the enzyme was detected, indicating that nitro compounds are not in-
termediates in the glucosinolate pathway. The form of the oxidized 
oxime might be the corresponding aci-nitro compounds (8) or nitrile 
oxides4 (Figure 8), which are interconvertible by a simple dehydra-
tion/hydration reaction and which are very reactive compounds and 
subject to nucleophilic attack by e.g. cysteine. Based on the expected 
strong reactivity of the oxidized oxime, conjugation of the sulfur do-
nor is likely to be under strict control. The proposed cysteine conju-
gation might be carried out by a glutathione S-transferase. Alterna-
tively, CYP83B1 may have a binding site not only for the oxime but 
also for cysteine. In the absence of added sulfur donor, an unidenti-
fi ed compound (X) accumulated in the reaction mixture. This com-
pound might be a furoxan (1,2,5-oxadiazole 2-oxide) formed by di-
merization of nitrile oxide, or it might be a conjugate derived from 
a nucleophile present in the reaction mixture. Further studies are in 
progress to elucidate the mechanism for the formation of the cyste-
ine conjugate. 
Cyanogenic glucosides and glucosinolates are related groups of 
natural plant products derived from amino acids and with oximes 
as intermediates. Cyanogenic glucosides occur throughout the plant 
kingdom. This indicates that cyanogenesis arose as a very early evo-
lutionary event. In contrast, glucosinolates are restricted to the order 
Capparales and the genus Drypetes in the distant order Euphorbiales 
(25). Cytochromes P450 belonging to the CYP79 family have been 
shown to catalyze the conversion of amino acids to oximes in both 
the cyanogenic and the glucosinolate pathway (3-7, 26), supporting 
the speculation that the biosynthesis of glucosinolates has evolved 
from the cyanogenic pathway (27). 
If evolution of glucosinolates is based on a “cyanogenic predis-
position,” this raises the question of how glucosinolates evolved. 
In the biosynthetic pathway of the cyanogenic glucoside dhurrin in 
S. bicolor, the oxime-metabolizing enzyme P450ox (CYP71E1) con-
verts the oxime to a α-hydroxynitrile (26). Our working hypothesis 
has been that a mutated homologue of P450ox, P450mox, catalyzes 
the oxime-metabolizing step in the biosynthetic pathway of gluco-
sinolates (Figure 9). According to the hypothesis, P450mox would 
oxidize the oxime to a toxic or reactive compound such as an aci-
nitro or a nitrile oxide, which the plant subsequently would have to 
detoxify. The post-oxime enzymes include the proposed glutathi-
one S-transferase and C-S lyase in addition to the known glucosyl-
transferase and sulfotransferase. These enzyme groups are known to 
be involved in general detoxifi cation reactions. This makes it likely 
that post-oxime enzymes have been recruited from the detoxifi ca-
tion processes but now are specialized for glucosinolate production. 
Several mutants of CYP83B1 have been reported (20, 28, 29). Re-
cently, CYP83B1 was described as a regulator of auxin production 
by controlling the fl ux of indole-3-acetaldoxime into indole-3-acetic 
acid and indole glucosinolates (29). Characterization of recombinant 
CYP83B1 expressed in yeast showed that indole-3-acetaldoxime is 
a high affi nity substrate for CYP83B1. The product obtained was 
shown to form adducts with a number of thiol compounds (29). It has 
been suggested that the glucosinolate pathway evolved from an in-
dole-3-acetic acid biosynthetic pathway and not necessarily from the 
cyanogenic pathway (29). Cyanogenic glucosides are derived from 
only fi ve protein amino acids (Tyr, Phe, Leu, Ile, and Val). The same 
few protein amino acids are also precursors for glucosinolates to-
gether with tryptophan, alanine, methionine, and chain-elongated de-
rivatives of methionine and phenylalanine, which are not precursors 
of cyanogenic glucosides. This suggests that CYP79s of the glucosin-
olate pathway have acquired new substrate specifi cities after having 
diverged from the “cyanogenic” CYP79s. The biosynthesis of trypto-
phan-derived and chain-elongated amino acid-derived glucosinolates 
seems to be recent evolutionary events because indole glucosinolates 
are present in only four families in the order Capparales, namely in 
the Brassicaceae, Resedaceae, Tovaraceae, and Capparaceae (30), 
and because glucosinolates from chain-elongated amino acids are 
only found in Brassicaceae, Resedaceae, and Capparaceae (1). Con-
sidering the taxonomical distribution of cyanogenic glucosides and 
glucosinolates in the plant kingdom and of indole glucosinolates in 
only four families in the Capparales order (30), it appears likely that 
glucosinolates have evolved from a cyanogenic predisposition. 
4 A. Kjær, personal communication.
Figure 7.   Substrate binding spectra obtained with recombinant CYP83B1. 
Each cuvette contained 0.25 nmol of recombinant CYP83B1 partly purifi ed into a 
Triton X-114 detergent-rich phase. 0.2 mM of substrate was added to the sample 
cuvette, and spectra were recorded at 12 °C after 45 min.
Figure 8.   The conversion of oxime to thiohydroximic acid in the glucosino-
late pathway. It is presently not known whether the oxime is oxidized to an aci-
nitro compound or a nitrile oxide by CYP83B1.
Figure 9.   The evolutionary relationship between cyanogenic glucosides and 
glucosinolates. Identifi cation of the oxime-metabolizing enzyme in the glucosin-
olate pathway (CYP83B1/P450mox) as related to the oxime-metabolizing enzyme 
in the cyanogenic pathway (CYP71E1/P450ox) is consistent with the hypoth-
esis that the P450ox in the cyanogenic pathway was mutated into a “P450mox” 
that converted the oxime into a toxic compound that the plant detoxifi ed into a 
glucosinolate.
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The CYP71 family is the largest cytochrome P450 family in 
A. thaliana with 47 members that cluster into different subgroups 
(Figure 4). In the Arabidopsis genome, another member of the CYP83 
family, CYP83A1, with 65% identity to CYP83B1 at the amino acid 
level has been identifi ed. The high sequence similarity suggests that 
CYP83A1 may be an oxime-metabolizing enzyme in the glucosino-
late pathway. The two CYP83s form a little subgroup that is located 
close to the CYP71E1, which is consistent with an evolutionary rela-
tionship between the oxime-metabolizing enzymes in the cyanogenic 
and the glucosinolate pathway. 
Within the last few years considerable advances in our under-
standing of glucosinolate biosynthesis have been achieved. Identi-
fi cation of the oxime-metabolizing enzymes in both the cyanogenic 
and the glucosinolate pathways combined with identifi cation of sub-
strate-specifi c oxime-producing CYP79s provides important molec-
ular tools for metabolic engineering of glucosinolate profi les and for 
introduction of cyanogenic glucosides and other oxime-derived com-
pounds in a glucosinolate or a non-glucosinolate background. 
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